← Back to News

Mizuho Raises its Price Target on Humana (HUM)

positiveAnalyst ratingMulti dayYahoo Finance ·13 Jun 2026Original article ↗
Oraklio AI Analysis

Bullish analyst target/rating changes typically influence near-term sentiment, but the target company’s ticker is not available in active_symbols.

Article

Mizuho Raises its Price Target on Humana (HUM) Jeff Lewis Sat, June 13, 2026 at 6:53 PM GMT+2 2 min read HUM Humana Inc. (NYSE:HUM) is one of the 7 Best Turnaround Stocks to Buy in 2026 . On June 8, 2026, Mizuho raised the firm’s price target on Humana Inc.

(NYSE:HUM) to $390 from $335 and maintained an Outperform rating on the shares. The firm said the managed care sector is entering a “more stable and predictable” policy environment, with the magnitude and frequency of policy-related surprises likely to moderate from the elevated levels of the past three years. Mizuho said that the backdrop should allow investors to focus on company fundamentals, pricing recovery, and the sector’s embedded earnings power.

On June 3, 2026, Bernstein analyst Lance Wilkes raised the firm’s price target on Humana Inc. (NYSE:HUM) to $425 from $288 and maintained an Outperform rating on the shares. Wilkes said Humana offers attractive EPS upside, with CAGR EPS growth of around 50% driven by Medicare Advantage sector margin recovery beginning this year and Humana-specific Stars recovery in 2028/2029.

On June 1, 2026, Humana reaffirmed its FY26 adjusted EPS guidance of “at least $9. 00. ” Mizuho Raises its Price Target on Humana (HUM) On May 20, 2026, Deutsche Bank upgraded Humana Inc.

(NYSE:HUM) to Buy from Hold with a price target of $441, up from $235. The firm cited a stabilizing managed care market and said it expects Humana’s Medicare star ratings to recover. Earlier, Humana reported Q1 adjusted EPS of $10.

31, compared with the consensus of $10. 20. CEO Jim Rechtin said the company had a solid start to the year and continues to make progress on customer experience and care.

Humana Inc. (NYSE:HUM) provides medical and specialty insurance products in the United States through its Insurance and CenterWell segments. While we acknowledge the potential of HUM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk.

If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the   best short-term AI stock . READ NEXT:  33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy .   Disclosure: None.

Follow Insider Monkey on Google News .

Oraklio AI Trading Intelligence

News is just the start.

Oraklio turns news, price data, and market signals into structured BUY / SELL / NO_TRADE calls - updated continuously throughout the trading day.

Get started free

Already have an account? Sign in →